Methylophiopogonanone ACAS# 74805-92-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 74805-92-8 | SDF | Download SDF |
PubChem ID | 53466984 | Appearance | Light yellow powder |
Formula | C19H18O6 | M.Wt | 342.34 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in chloroform and methanol; insoluble in water | ||
Chemical Name | (3R)-3-(1,3-benzodioxol-5-ylmethyl)-5,7-dihydroxy-6,8-dimethyl-2,3-dihydrochromen-4-one | ||
SMILES | CC1=C(C2=C(C(=C1O)C)OCC(C2=O)CC3=CC4=C(C=C3)OCO4)O | ||
Standard InChIKey | BXTNNJIQILYHJB-GFCCVEGCSA-N | ||
Standard InChI | InChI=1S/C19H18O6/c1-9-16(20)10(2)19-15(17(9)21)18(22)12(7-23-19)5-11-3-4-13-14(6-11)25-8-24-13/h3-4,6,12,20-21H,5,7-8H2,1-2H3/t12-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Methylophiopogonanone A has anti-inflammatory and anti-oxidative properties, it also has therapeutic potential against cerebral I/R injury through its ability to attenuate BBB disruption by regulating the expression of MMP-9 and tight junction proteins. |
Targets | MMP(e.g.TIMP) |
In vivo | Methylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In Vitro.[Pubmed: 25897666]PLoS One. 2015 Apr 21;10(4):e0124558.Methylophiopogonanone A (MO-A), an active homoisoflavonoid of the Chinese herb Ophiopogon japonicus which has been shown to have protective effects on cerebral ischemia/reperfusion (I/R) injury, has been demonstrated to have anti-inflammatory and anti-oxidative properties. However, little is known about its role in cerebral I/R injury. |
Structure Identification | Chinese Traditional & Herbal Drugs, 2015, 46(20):3091-5.Comparison on homoisoflavones extracted from Ophiopogon japonicus in Sichuan and Zhejiang and their anti-oxidative activity.[Reference: WebLink]To compare the contents of three homoisoflavones and their anti-oxidative activity of Ophiopogon japonicus in Sichuan(OJS) and Zhejiang(OJZ). |
Methylophiopogonanone A Dilution Calculator
Methylophiopogonanone A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.9211 mL | 14.6054 mL | 29.2107 mL | 58.4215 mL | 73.0268 mL |
5 mM | 0.5842 mL | 2.9211 mL | 5.8421 mL | 11.6843 mL | 14.6054 mL |
10 mM | 0.2921 mL | 1.4605 mL | 2.9211 mL | 5.8421 mL | 7.3027 mL |
50 mM | 0.0584 mL | 0.2921 mL | 0.5842 mL | 1.1684 mL | 1.4605 mL |
100 mM | 0.0292 mL | 0.1461 mL | 0.2921 mL | 0.5842 mL | 0.7303 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Methylophiopogonanone B
Catalog No.:BCN5418
CAS No.:74805-91-7
- Methylophiopogonone A
Catalog No.:BCN2841
CAS No.:74805-90-6
- Methylophiopogonone B
Catalog No.:BCN8182
CAS No.:74805-89-3
- Ciglitazone
Catalog No.:BCC7014
CAS No.:74772-77-3
- VER-50589
Catalog No.:BCC5296
CAS No.:747413-08-7
- AUY922 (NVP-AUY922)
Catalog No.:BCC2123
CAS No.:747412-49-3
- Pterolactone A
Catalog No.:BCN6513
CAS No.:74730-10-2
- Secoxyloganin methyl ester
Catalog No.:BCN4299
CAS No.:74713-15-8
- Zaltoprofen
Catalog No.:BCC4442
CAS No.:74711-43-6
- 5-Hydroxyxanthotoxin
Catalog No.:BCC8107
CAS No.:7471-73-0
- Hydroxychloroquine Sulfate
Catalog No.:BCC5560
CAS No.:747-36-4
- Vibsanin C
Catalog No.:BCN4590
CAS No.:74690-89-4
- Zalcitabine
Catalog No.:BCC5026
CAS No.:7481-89-2
- 3',5'-Anhydrothymidine
Catalog No.:BCC8596
CAS No.:7481-90-5
- GRP (porcine)
Catalog No.:BCC5809
CAS No.:74815-57-9
- Boc-Hyp-Ome
Catalog No.:BCC3252
CAS No.:74844-91-0
- Argatroban
Catalog No.:BCC3723
CAS No.:74863-84-6
- alpha-Carotene
Catalog No.:BCN3880
CAS No.:7488-99-5
- Vernakalant Hydrochloride
Catalog No.:BCC2037
CAS No.:748810-28-8
- 5-Carboxamidotryptamine maleate
Catalog No.:BCC6652
CAS No.:74885-72-6
- 5-Acetoxymatairesinol dimethyl ether
Catalog No.:BCN4300
CAS No.:74892-45-8
- Piracetam
Catalog No.:BCC4824
CAS No.:7491-74-9
- DMAT
Catalog No.:BCC1533
CAS No.:749234-11-5
- Allyl phenoxyacetate
Catalog No.:BCC8813
CAS No.:7493-74-5
Methylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In Vitro.[Pubmed:25897666]
PLoS One. 2015 Apr 21;10(4):e0124558.
Methylophiopogonanone A (MO-A), an active homoisoflavonoid of the Chinese herb Ophiopogon japonicus which has been shown to have protective effects on cerebral ischemia/reperfusion (I/R) injury, has been demonstrated to have anti-inflammatory and anti-oxidative properties. However, little is known about its role in cerebral I/R injury. Therefore, in this study, by using a middle cerebral artery occlusion (MCAO) and reperfusion rat model, the effect of MO-A on cerebral I/R injury was examined. The results showed that MO-A treatment reduced infarct volume and brain edema, improved neurological deficit scores, reversed animal body weight decreases, and increased animal survival time in the stroke groups. Western blotting showed that MO-A suppressed MMP-9, but restored the expression of claudin-3 and claudin-5. Furthermore, transmission electron microscopy were monitored to determine the blood-brain barrier (BBB) alterations in vitro. The results showed that MO-A markedly attenuated BBB damage in vitro. Additionally, MO-A inhibited ROS production in ECs and MMP-9 release in differentiated THP-1 cells in vitro, and suppressed ICAM-1 and VCAM-1 expression in ECs and leukocyte/EC adhesion. In conclusion, our data indicate that MO-A has therapeutic potential against cerebral I/R injury through its ability to attenuate BBB disruption by regulating the expression of MMP-9 and tight junction proteins.